Your browser doesn't support javascript.
loading
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
Cooper, D S; Specker, B; Ho, M; Sperling, M; Ladenson, P W; Ross, D S; Ain, K B; Bigos, S T; Brierley, J D; Haugen, B R; Klein, I; Robbins, J; Sherman, S I; Taylor, T; Maxon, H R.
Affiliation
  • Cooper DS; Division of Endocrinology, Sinai Hospital of Baltimore, and The Johns Hopkins University School of Medicine, Maryland 21215, USA.
Thyroid ; 8(9): 737-44, 1998 Sep.
Article in En | MEDLINE | ID: mdl-9777742
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Thyroxine / Thyrotropin / Carcinoma, Papillary / Adenocarcinoma, Follicular Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Thyroid Journal subject: ENDOCRINOLOGIA Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Thyroxine / Thyrotropin / Carcinoma, Papillary / Adenocarcinoma, Follicular Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Thyroid Journal subject: ENDOCRINOLOGIA Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States